PAVmed to Hold a Business Update Conference Call and Webcast on November 13, 2025

Rhea-AI Summary

PAVmed (NASDAQ: LUCD) will host a business update conference call and webcast on November 13, 2025 at 8:30 AM ET. The call will feature Lishan Aklog, M.D., chairman and CEO, providing an overview of operations and growth strategy, and Dennis McGrath, president and CFO, discussing the company’s third quarter 2025 financial results.

The live webcast will be available in the investor relations section of pavmed.com. U.S. callers can join by dialing 1-800-836-8184; international listeners can dial 1-646-357-8785 and should request the conference name "PAVmed Business Update." A replay will be available on the investor relations website for 30 days after the call.

Conference Call and Webcast at 8:30 AM Eastern Time

NEW YORK, Oct. 30, 2025 /PRNewswire/ -- PAVmed Inc. (Nasdaq: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today announced that it will host a business update conference call and webcast on Thursday, November 13, 2025, at 8:30 AM ET. During the call, Lishan Aklog, M.D., PAVmed's Chairman and Chief Executive Officer, will provide a business update including an overview of the Company's operations and growth strategy. In addition, Dennis McGrath, PAVmed's President and Chief Financial Officer, will discuss the Company's third quarter 2025 financial results.

The webcast will be available at the investor relations section of the Company's website at pavmed.com. Alternatively, to access the conference call by telephone, U.S.-based callers should dial 1-800-836-8184 and international listeners should dial 1-646-357-8785. All listeners should provide the operator with the conference call name "PAVmed Business Update" to join.

Following the conclusion of the conference call, a replay will be available for 30 days on the investor relations section of the Company's website at pavmed.com.

About PAVmed
PAVmed Inc. is a diversified commercial-stage medical technology company operating in the medical device, diagnostics, and digital health sectors. Its subsidiary, Lucid Diagnostics (Nasdaq: LUCD), is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard^® Esophageal DNA Test and EsoCheck^® Esophageal Cell Collection Device—the first and only commercial tools for widespread early detection of esophageal precancer to mitigate the risks of esophageal cancer deaths. Its other subsidiary, Veris Health Inc., is a digital health company focused on enhanced personalized cancer care through remote patient monitoring using implantable biologic sensors with wireless communication along with a custom suite of connected external devices. Veris is concurrently developing an implantable physiological monitor, designed to be implanted alongside a chemotherapy port, which will interface with the Veris Cancer Care Platform.

For more and for more information about PAVmed, please visit pavmed.com.

For more information about Lucid Diagnostics, please visit luciddx.com.

For more information about Veris Health, please visit verishealth.com. 

View original content to download multimedia:https://www.prnewswire.com/news-releases/pavmed-to-hold-a-business-update-conference-call-and-webcast-on-november-13-2025-302598093.html

SOURCE PAVmed Inc.

FAQ

When is the PAVmed (LUCD) business update conference call?

The PAVmed business update conference call is on November 13, 2025 at 8:30 AM ET.

Who will present on the PAVmed (LUCD) November 13, 2025 call?

Lishan Aklog, M.D. (chairman and CEO) and Dennis McGrath (president and CFO) will present.

Where can investors watch the PAVmed (LUCD) webcast for the November 13, 2025 call?

The live webcast will be available in the investor relations section of pavmed.com.

How can I call into the PAVmed (LUCD) November 13, 2025 conference call by phone?

U.S. callers dial 1-800-836-8184; international callers dial 1-646-357-8785 and give the operator the conference name "PAVmed Business Update."

Will a replay of the PAVmed (LUCD) November 13, 2025 call be available?

Yes. A replay will be posted on the investor relations section of pavmed.com and will be available for 30 days.